This is a reply to a comment below by diet1900 which I thought I would add here :
"It is a pleasure and that is why I keep updating my analysis. For those who want to sit back maybe rather buy something else or be willing to really wait for your investment to pay off.
However most of Sasol's internal problems are out on the table now and people have seen Sasol acting and hearing from them how they will act moving forward. Not everyone agrees with Sasol's 50% sale of Lake Charl's and how they are going about it, however I must still commend the management team. As a retail trader who is looking at trades anything from hours to +_6 months in advance, right now the income lost from the sale of Lake Charls in the future was never there before to start with so they basically went from having nothing that works to owning 50%% now of a really valuable division especially during Covid and the sanitizer chemicals they provide. So that is a plus, secondly the upcoming rights issue in 2021...How many people really think they will still hold their money in this stock at the time... I will surely start selling off if I see that the rights issue will affect my holdings. But in a 1 to 6 Months non of those should matter... Unless you are buying for future dividends get out at a sensible level, this stock being so volatile you could make a years living in one day with Sasol trading it.
With
Pfizer - Already
Moderna - Results Coming
AstraZeneca - Results Coming
Inovio - Results Coming
Sanofi - Results Coming
CanSino Biologics - Results Coming
Johnson & Johnson - Results Coming
Sanofi / GSK / TranslateBio. Drugmaker Sanofi is pursuing two vaccines. - Results Coming
Novavax - Results Coming
University of Queensland in Australia / CSL - Results Coming
and 5 more places I could quickly find have vaccines that looks promising and that will rocket confidence in a recovery again as seen with Pizer.. however I do believe the more candidates gets approved the more Sasol will hold its gains and finally break back into the R120 Support
Therapeutics -
Regenaron - Result Coming
Remdisviir - Already Approved
Dexamethasone - In use
and more out there already announced and still to come so don't give up, If you entered low enough you will make money, If you entered high you might need to wait but you will break even, Sasol has not hit one price point on its rally up that it won't see again in the future so keep patients. The last time I predicted a break to R150 it did, however still to my surprise peaked at R186.. Not going to lie it hurt getting out at R155 and then seeing it hit R186 and not selling the rest there... but I have climbed back into Sasol with around 500 times the capital I did in the start at R60, so you can believe my confidence and relentless pursuit for the right analysis and forecast.
Aspen APN is another stock to watch right now. Watching the trend and plotting the data of the last 7 months there seems to be strong correlation with Sasol...Not sure why,
and they seem to rocket even on the news on other pharma firms."